Simon Barry J. sold IBRX

February 24, 2026 · Form 4 insider transaction

Simon Barry J. sold 75,000 shares of ImmunityBio, Inc. at $12.01 per share, a transaction worth $900.8K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.

Direction
Disposed (sell-side)
Shares
75,000
Price
$12.01
Total value
$900.8K
Role—
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateFebruary 24, 2026
Filing dateFebruary 26, 2026
Shares owned after2,850,821
OwnershipDirect
10b5-1 planYes
AmendedNo

Footnotes

The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 4, 2024.; Represents the weighted average share price of an aggregate total of 75,000 shares sold in the price range of $12.00 to $12.025 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, ImmunityBio, Inc. (the "Issuer") or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.

View the original Form 4 on SEC EDGAR
Simon Barry J. sold IBRX: February 24, 2026 | Insider Trading Screener